MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
NOVO.B.DK Novo Nordisk A/S Class B 70.0 ¤323,877 DK
ASML.NL ASML Holding NV 76.2 ¤291,072 NL
RO.CH Roche Holding Ltd 58.8 ¤273,915 CH
OR.FR L'Oreal S.A. 54.0 ¤227,069 FR
AZN.GB AstraZeneca PLC 66.4 ¤222,291 GB

Five Smallest Companies
Symbol Name Grade Market Cap Country
EVO.SE Evolution AB 70.6 ¤13,395 SE
INDU.C.SE Industrivarden AB Class C 34.0 ¤15,670 SE
SGE.GB Sage Group plc 57.8 ¤16,033 GB
A5G.IE AIB Group plc 81.2 ¤16,984 IE
8TRA.DE TRATON SE 53.9 ¤17,203 DE

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 76.2 32 NL
ACN Accenture Plc Class A 60.7 31 IE
DNB.NO DNB Bank ASA 69.4 28 NO
ALV.DE Allianz SE 44.8 27 DE
NOVO.B.DK Novo Nordisk A/S Class B 70.0 27 DK
ASSA.B.SE ASSA ABLOY AB Class B 50.6 26 SE
TEL TE Connectivity plc 49.8 25 IE
ETN Eaton Corp. Plc 57.6 24 IE
VOLV.B.SE Volvo AB Class B 54.0 24 SE
IFX.DE Infineon Technologies AG 44.3 23 DE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤66,824
Median Market Cap ¤40,857
Avg. 3 Mo. Dollar Vol. ¤178,629,445
Avg. 3 Mo. Trading Vol. 4,880,821
Last Rebalance Date 03/24/2025
Companies Replaced 35
Biggest Sector Increase Consumer Staples
Biggest Sector Decrease Energy

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 17.1
Forward P/E Ratio (12 Mo.) 14.6
Price/Book Ratio 2.8
Avg. Revenue Chg. - 3 Yr 28.6%
Avg. Op. Income Chg. - 3 Yr. 39.4%
Avg. EPS Growth - 3 Yr. 13.3%
Avg. EPS Growth - 1 Yr. 12.4%
Avg. Operating Margin 19.1%
Avg. LT Debt to Total Capital 46.9%
Avg. Return on Equity 17.3%
Dividend Yield 2.5%
Index Average Grade
Europe 100 Index 57.32
Country Breakdown
United Kingdom 18.0%
Sweden 14.0%
Ireland 11.0%
Switzerland 11.0%
Germany 10.0%
Spain 6.0%
Italy 6.0%
Netherlands 6.0%
France 6.0%
Denmark 4.0%
Finland 2.0%
Austria 2.0%
Norway 2.0%
Belgium 1.0%
Czech Republic 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE